abstract |
The present invention relates to compositions comprising an inhibitor of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, as well as to subjects in need thereof for the treatment of cancer. It relates to a method of combination therapy for administration. |